Setting Up a New Pharmaceutical QC Laboratory in Ireland — A Comprehensive Guide

Setting up a pharmaceutical QC laboratory in Ireland means building into one of the most heavily scrutinised — and most internationally respected — regulatory environments in the world. Ireland is home to more than 85 biopharmaceutical companies, including all of the world's ten largest pharmaceutical companies, and ranks among the top five pharmaceutical exporters globally, with the sector's exports reaching close to €100 billion in 2024 alone (IDA Ireland, IDA Ireland). That density of activity means a new QC laboratory — whether inside a manufacturing site, as a standalone contract testing facility, or supporting an academic or research programme — is entering a market where regulators, auditors, and customers already hold a high bar for what "compliant" looks like.

This guide walks through the practical building blocks of setting up a pharmaceutical QC laboratory in Ireland: the regulatory foundations you need to understand before you buy a single instrument, how to decide between GMP-aligned and ISO 17025 accreditation routes, facility and utility planning, core equipment selection, qualification and validation, documentation systems, staffing, and the pitfalls that tend to catch new labs out.

Why Ireland's Regulatory Reputation Matters From Day One

Ireland's national medicines regulator, the Health Products Regulatory Authority (HPRA), is a well-regarded body within the European Medicines Agency regulatory network, and Irish biopharma manufacturing facilities consistently perform strongly in inspections by international health agencies (IDA Ireland). Setting up a new laboratory here is not simply a matter of installing equipment and hiring analysts — it means designing a facility and quality system from the outset that will hold up under HPRA inspection, and in many cases under FDA or other international agency inspection as well, since Irish sites frequently supply global markets.

This has a practical implication for anyone planning a new lab: decisions that seem minor early on — how a Standard Operating Procedure is worded, how an instrument's qualification is documented, how a supplier is selected — are the details an inspector will pull on. Building the right foundations from the start is considerably cheaper than retrofitting compliance onto an operating lab later.

Understanding the Regulatory Pathway: Do You Need a Manufacturer's Authorisation?

The first and most consequential question when setting up a pharmaceutical QC laboratory in Ireland is whether the lab needs to be included on a Manufacturer's/Importer's Authorisation (MIA), or whether it will operate as a standalone contract testing laboratory outside that scope.

Under HPRA guidance, a manufacturing authorisation is required for the manufacture, packaging, labelling, and importation of medicinal products, and this extends to quality control testing that supports batch release. Contract laboratories that test human medicines do not require their own MIA if they are named on the contract-giver's MIA as a contract laboratory — in this case, they are included in the HPRA's routine GMP inspection programme and issued a GMP certificate where compliant (HPRA). Laboratories testing veterinary medicinal products, by contrast, are required to hold their own MIA under Regulation (EU) 2019/6.

For a new QC laboratory, this means the very first planning decision is: will this lab be named on an existing manufacturer's authorisation as a contract testing facility, or does it need to pursue its own authorisation? The HPRA offers pre-submission meetings for companies planning to apply for an MIA within six months, specifically to discuss the pharmaceutical quality system and qualification activities for premises and equipment before the formal application is lodged (HPRA). Engaging with this process early — rather than building the lab first and seeking authorisation second — is the difference between a smooth review and a costly redesign.

GMP vs ISO 17025: Choosing the Right Quality Framework

Not every laboratory needs the same regulatory framework, and choosing the wrong one is a common early mistake. Broadly, two frameworks apply to analytical laboratories in Ireland:

• GMP (Good Manufacturing Practice) — Applies where the lab's testing directly supports batch release or manufacturing decisions for licensed medicinal products, and falls under the scope of a manufacturer's authorisation, whether the lab's own or a contract-giver's.
• ISO/IEC 17025:2017 accreditation — The international standard for the general competence of testing and calibration laboratories, administered in Ireland by the Irish National Accreditation Board (INAB). This standard governs quality system requirements including document control, method validation, measurement traceability, and handling of non-conforming results (INAB).

Many analytical service laboratories — particularly those offering environmental, water, food, or general chemical testing rather than direct pharmaceutical batch release — operate under ISO 17025 accreditation rather than a full GMP manufacturer's authorisation. Some laboratories, particularly larger contract testing organisations, hold both. Understanding which framework your intended scope of testing actually requires — before committing to a facility design — avoids building to a higher (and more expensive) standard than necessary, or discovering partway through setup that a more rigorous framework is required than originally planned.

Facility Design and Utility Planning

Facility layout for a pharmaceutical QC laboratory needs to be planned around workflow segregation and contamination control from the earliest design stage, not retrofitted afterward. Key planning considerations include:

• Segregation of testing areas — Wet chemistry, instrumental analysis, microbiology (if applicable), and sample receipt/storage areas typically need physical or procedural separation to prevent cross-contamination and mix-ups.
• Environmental monitoring and control — Temperature and humidity-controlled areas for reference standards, reagents, and stability samples, with continuous monitoring and alarm systems where required by the test methods in scope.
• Utilities — Reliable power (with backup for critical equipment such as stability chambers and freezers), purified water systems where wet chemistry or mobile phase preparation requires it, and appropriate extraction/ventilation for solvent-based methods.
• Sample and reference standard security — Controlled access storage for retained samples, reference standards, and controlled substances where applicable.
• Space for growth — Given that Ireland's biopharma sector has grown employment by roughly 20,000 over the past decade to more than 50,000 today (IDA Ireland), it is worth designing bench and storage capacity with expansion in mind rather than for day-one headcount only.

Core Equipment for a Pharmaceutical QC Laboratory

The specific instrument list depends heavily on the product types and test methods in scope, but most pharmaceutical QC laboratories in Ireland build around a common core:

A recurring theme across all of these categories is that the consumables and glassware supporting an instrument — volumetric flasks, pipettes, autosampler vials, filters — are just as much a part of method validity as the instrument itself, and should be sourced and qualified with the same rigour applied to the instruments they support.

To illustrate with concrete examples: a new lab's analytical bench might combine a microvolume UV-Vis spectrophotometer or fluorometer for nucleic acid and protein quantification, a gradient PCR thermocycler for molecular biology work, a digital magnetic stirrer for reagent preparation, and Class A volumetric glassware for accurate solution preparation — each qualified and calibrated as part of the same equipment qualification programme described below.

Equipment Qualification: IQ, OQ, PQ

Every piece of GMP-critical equipment entering a pharmaceutical QC laboratory needs to be qualified before routine use, under the framework set out in EU GMP Annex 15: Qualification and Validation. Annex 15 defines three sequential stages: Installation Qualification (IQ) — documented verification that equipment, as installed, complies with its approved design and manufacturer's recommendations; Operational Qualification (OQ) — documented verification that the equipment performs as intended across its expected operating range; and Performance Qualification (PQ) — documented evidence that the equipment performs consistently and reproducibly for its intended routine use (European Commission, EudraLex Volume 4, Annex 15).

In practice, IQ/OQ/PQ provides the documented evidence an inspector expects to see connecting an instrument's physical installation to the reliability of the analytical data it produces — and gaps here are a well-known GMP inspection finding. For simple, well-understood laboratory equipment such as balances or pH meters, this qualification can typically be completed in a matter of days; more complex instrumentation may take longer, particularly where multiple operating parameters need to be verified across their full working range (GoValidation). Whatever the equipment, qualification needs to be revisited — not just repeated — whenever a significant change occurs: relocation, a firmware update, a repair affecting a critical component, or a change in intended use.

Calibration and Traceability

Alongside qualification, every measuring instrument in a QC laboratory needs an ongoing calibration programme with traceability to national or international measurement standards. In Ireland, calibration laboratories are themselves accredited by INAB to ISO/IEC 17025, and a new QC lab should build its calibration schedule — covering balances, thermometers, pipettes, incubators, and similar equipment — around suppliers holding this accreditation, since traceable calibration is a foundational expectation in both GMP and ISO 17025 audits (INAB).

Building the Quality Management System

Equipment and facilities are only half of a compliant QC laboratory — the other half is the documented quality system that governs how the lab operates day to day. At minimum, a new pharmaceutical QC laboratory needs:

• Standard Operating Procedures (SOPs) covering every routine activity, from sample receipt to instrument use to data review
• Analytical method validation or verification records demonstrating each test method is fit for its intended purpose
• A document control system managing SOP versions, approvals, and periodic review
• Deviation and CAPA (Corrective and Preventive Action) procedures for handling out-of-specification results and other non-conformances
• Training records demonstrating analysts are qualified to perform the methods assigned to them
• A supplier qualification programme for reagents, reference standards, and consumables — an area that is often under-resourced relative to its actual risk to data integrity
• An internal audit and self-inspection schedule

For laboratories seeking ISO 17025 accreditation specifically, the standard requires a documented management system covering areas including complaint handling, contract review, purchasing, and internal audits, applicable regardless of the laboratory's size or scope of testing (INAB).

Staffing and the Qualified Person Question

Staffing a new pharmaceutical QC laboratory in Ireland involves more than hiring analysts with the right technical background. Where a laboratory operates under a manufacturer's authorisation, HPRA guidance sets out detailed educational, training, and licensing requirements for individuals seeking Qualified Person (QP) status — the role legally responsible for certifying batches for release — including specific requirements around Pharmaceutical Society of Ireland registration where relevant (HPRA). Even where a lab does not require its own QP — for example, a standalone contract testing lab — analysts still need documented, method-specific training and competency assessment before performing GMP-relevant testing independently.

Timeline and Practical Sequencing

A realistic sequence for setting up a pharmaceutical QC laboratory in Ireland typically looks like this:

1. Define scope and regulatory pathway — Confirm whether the lab needs its own MIA, will be named on a contract-giver's MIA, will pursue ISO 17025 accreditation, or some combination, before any facility or equipment decisions are made.
2. Engage HPRA early where an MIA is involved — Use the pre-submission meeting process to align facility and equipment plans with HPRA expectations before construction or fit-out begins.
3. Design and fit out the facility — Segregated workflow areas, environmental controls, and utilities sized for both current scope and near-term growth.
4. Select and qualify equipment — Define user requirements before purchase, then complete IQ/OQ/PQ for each piece of GMP-critical equipment before routine use.
5. Build the quality management system — SOPs, method validations, training programmes, and document control, developed in parallel with facility fit-out rather than after it.
6. Complete method transfer or validation — Demonstrate that analytical methods perform as expected in the new facility, on the newly qualified equipment, before routine testing begins.
7. Regulatory inspection or accreditation assessment — HPRA inspection (where an MIA is involved) or INAB assessment (for ISO 17025 accreditation) to confirm the lab is ready for live testing.

Common Pitfalls When Setting Up a New QC Lab

A few recurring issues show up across new laboratory setups, regardless of size or product focus:

• Buying equipment before defining the regulatory pathway — leading to instruments that are technically capable but poorly matched to the qualification and documentation burden the lab actually needs to carry.
• Treating supplier qualification as an afterthought — particularly for consumables and glassware, which directly affect method performance and data integrity but are often purchased through informal channels rather than a proper vendor qualification process.
• Under-sizing environmental monitoring and utilities — retrofitting temperature mapping, backup power, or extraction after fit-out is significantly more disruptive and costly than designing for it from the outset.
• Delaying HPRA or INAB engagement — early conversations with the regulator or accreditation body surface expectations that are far cheaper to address at the design stage than after equipment is installed and SOPs are written.
• Under-resourcing documentation in parallel with construction — a lab that is physically ready months before its quality system is complete simply sits idle, or worse, begins informal testing before formal qualification is finished.

Conclusion

Setting up a pharmaceutical QC laboratory in Ireland means building for one of the most closely watched regulatory environments in the world — but also one of the most experienced, with deep local expertise in HPRA authorisation, GMP compliance, and ISO 17025 accreditation to draw on. Getting the regulatory pathway right first, designing the facility and equipment plan around that pathway, and building the quality management system in parallel with construction rather than after it, are the decisions that most reliably separate a smooth path to operational readiness from a costly one.

For further detail on manufacturer's authorisation requirements, refer to the Health Products Regulatory Authority (HPRA), and for laboratory accreditation guidance, refer to the Irish National Accreditation Board (INAB). To discuss sourcing the analytical instruments, glassware, and consumables needed to equip a new pharmaceutical QC laboratory, contact our team or browse our full product range below.

Related Reading

For guidance on specific instrument and glassware categories referenced above, see our Laboratory Glassware for Pharmaceutical QC guide, our Microvolume Spectrophotometry Guide, and our PCR Thermocycler Selection Guide.

Browse Our Full Range

Explore our complete range of laboratory instruments and glassware for pharmaceutical, biotechnology, research, and academic laboratories.